Duration of antibacterial treatment for uncomplicated urinary tract infection in women (Q24246889)

3

0 references

Thierry Christiaens

4

Thierry Christiaens

0 references

Gai Milo

1

Gai Milo

0 references

Eugene A Katchman

2

Eugene Katchman

0 references

Anders Bærheim

5

Cochrane Database of Systematic Reviews

Anders Baerheim

0 references

publication date

20 April 2005

0 references

published in

0 references

cites work

Comparison of three- and ten-day regimens with a sulfadiazine-trimethoprim combination and pivmecillinam in acute lower urinary tract infections.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Cefadroxil single-dose long and short therapy versus amoxicillin in female urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

A comparison of a 3-day course of Mictral with a 7-day course of ampicillin in the treatment of urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Summarized results of clinical phase II and III studies with ofloxacin (HOE 280) in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Three-day and ten-day chemotherapy for urinary tract infections in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid: A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Intracellular bacterial biofilm-like pods in urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

A prospective study of risk factors for symptomatic urinary tract infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Diagnosis and treatment of uncomplicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

A prospective study of asymptomatic bacteriuria in sexually active young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Causes of the acute urethral syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

A Multicenter Comparative Trial of Three-Day Norfloxacin vs Ten-Day Sulfamethoxazole and Trimethoprim for the Treatment of Uncomplicated Urinary Tract Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Treatment of uncomplicated urinary tract infections with temafloxacin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Randomized study to evaluate efficacy and safety of ofloxacin vs. trimethoprim and sulfamethoxazole in treatment of uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Treatment of urinary tract infections with varying regimens of sulfisoxazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Three-day treatment of urinary tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Acute cystitis: a prospective study of laboratory tests and duration of therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Diagnosis of coliform infection in acutely dysuric women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Short-term treatment of uncomplicated lower urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Natural history of recurrent urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

A controlled trial of norfloxacin and amoxycillin in the treatment of uncomplicated urinary tract infection in the elderly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Treatment of acute urinary tract infection with three doses of co-trimoxazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Comparative Efficacy of 3-Day and 7-Day Chemotherapy with Pivmecillinam in Urinary Tract Infections in General Practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Comparative efficacy of 3-day and 7-day chemotherapy with twice-daily pivmecillinam in urinary tract infections seen in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Does Valsalva leak point pressure predict outcome after the distal urethral polypropylene sling? Role of urodynamics in the sling era

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Comparison of 2 Oral Ofloxacin Regimens for the Treatment of Bacteriuria in Elderly Subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Cefadroxil once daily for three or seven days versus amoxycillin for seven days in uncomplicated urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021

A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004682.PUB2

7 January 2021